fbpx

FDA Warns Zantac May Contain Carcinogenic Contaminants

CONSUMER ALERT: Zantac, other OTC Medications Found To Contain Carcinogenic Contaminant

On September 13th, 2019, the FDA released an advisory warning American consumers that a contaminant known as N-nitrosodimethylamine (NDMA) was found to exist in numerous medicines, including the popular heartburn medication Zantac.

NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. Zantac may come in prescription or Over-The-Counter varieties, but so far all forms have been found to contain this contaminant. If you were prescribed or regularly used Zantac, or any other ranitidine-based medication, Kazerouni Law Group wants to meet with you, free of charge. You may be eligible for any medical expenses or pain and suffering you are going through.
Call Now
Email Us
Scroll to Top